China SXT Pharmaceuticals, Inc. logo

China SXT Pharmaceuticals, Inc. (SXTC)

Market Open
15 Jun, 14:39
NASDAQ (CM) NASDAQ (CM)
$
2. 50
-0.07
-2.7237%
$
1.36M Market Cap
- P/E Ratio
- Div Yield
36,741 Volume
0 Eps
$ 2.57
Previous Close
Investors:
Add Transaction
Day Range
2.49 2.68
Year Range
1.25 1,047
Want to track SXTC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

China SXT Pharmaceuticals, Inc. (SXTC) Statistics

Valuation metrics

Market Cap 1.36M
Enterprise value -17.98M
Trailing P/E (ttm) -2.51
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 2.18
Price/Book (mrq) 0.31
Enterprise Value/Revenue -19.72
Enterprise Value/EBITDA 8.86

Overview

Shares outstanding 773.52K
Float 702.05K
Shares short 63.86K
% Held by insiders 0.09%
% Held by institutions 0%
Average volume (10 days) 264.49K
Average volume (90 days) 80.41K

Price summary

52-Week low 1.25
52-Week high 1,047
Beta 1.75
50-Day moving average 1.77
200-Day moving average 52.26

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:150
Last split Date 3 Feb 2026

Financials

Fiscal year

Fiscal year ends 31 Mar 2025
Most recent quarter (mrq) 30 Sep 2025

Profitability

Profit margin -2.74%
Operating margin -2.24%

Operational effectiveness

Return on assets -0.09%
Return on equity -0.15%

Income Statement

Revenue (ttm) 1.54M
Revenue per share (ttm) 0.37
Quarterly revenue growth (yoy) -0.24%
Gross profit (ttm) 334.39K
EBITDA -8.34M
Net income to common (ttm) -8.87M
Diluted EPS (ttm) -1.02
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) 21.31M
Total cash per share (mrq) 8.67
Total debt (mrq) 1.2M
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 4.37%
Book value per share (mrq) 8.28

Cash Flow

Cash flow statement -2.74M
Levered free cash flow (LFCF) -1.95M